Netherlands· NL-60e13074a434
Docetaxel Hikma 80 mg/4 ml concentraat voor oplossing voor infusie
A docetaxel product containing docetaxel 0-water, registered in Netherlands by Hikma Farmaceutica (Portugal), S.A.. The same ATC class is registered in 16 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Docetaxel is registered in 16 of 19 countries.
Countries holding a registration under ATC L01CD02 (docetaxel), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Docetaxel · ATC L01CD02
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of docetaxel costs, country by country.
Normalised to the WHO defined daily dose (6.43 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Docetaxel · price per daily dose (6.43 mg)
USD · FX 28 Sept 2026
- CH Switzerland$21.58
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- DOCETAXEL 0-WATER
- Manufacturer
- Hikma Farmaceutica (Portugal), S.A.
- Country
- Netherlands (NL)
- ATC code
- L01CD02
- ATC class
- Docetaxel
- Defined daily dose
- 6.43 mg, P
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id132384
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
662 interactions on record for docetaxel.
Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Docetaxel · interactions on record
662 records
- 69 severe
- 302 moderate
- 21 minor
- 270 info
Most severe, free to view
- LonafarnibA16AX20severe
- AmiodaroneC01BD01severe
- DronedaroneC01BD07severe
- ConivaptanC03XA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Docetaxel in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceDOCETAXEL ACCORD 160 mg/8 ml, solution à diluer pour perfusionACCORD HEALTHCARE (ROYAUME UNI)
- United StatesBEIZRAYZhuhai Beihai Biotech Co., Ltd.
- United KingdomDocetaxel 108mg/250ml in Sodium chloride 0.9% infusion bagsSpecial Order
- BelgiumBaglycacon 10 mg/mlSandoz
- FinlandDocefrezSun Pharmaceutical Industries B.V.
- CzechiaDOCETAXEL ACCORDAccord Healthcare S.L.U., Barcelona
- SwedenDocetaxel Accord 160 mg/8 ml Koncentrat till infusionsvätska, lösningAccord Healthcare S.L.U.
- SpainDOCETAXEL ACCORD 160 mg/8 ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Docetaxel Ebewe, Docetaxel Hikma
- Belgium · Docetaxel Eugia, Docetaxel Hikma
- Bulgaria · Доцетаксел Булгермед, Доцетаксел Новамед
- Czechia · Docetaxel Ebewe
- Germany · Bendadocel, Doce
- Denmark · Docetaxel Ebewe, Docetaxel Stada
- Estonia · Docetaxel Ebewe
- Spain · Docetaxel Aurovit, Docetaxel Aurovitas
- Finland · Docetaxel Ebewe
- France · Docetaxel Arrow, Docetaxel Hikma
- United Kingdom (Northern Ireland) · Docetaxel Biotech Pharma, Docetaxel Hikma Farmacêutica (Portugal)
- Greece · Demotaxel, Demotaxel Mono
- Croatia · Docetaksel Teva, Docetaksel Zentiva
- Hungary · Docetaxel Seacross
- Ireland · Docetaxel Seacross Pharma (Europe)
- Iceland · Docetaxel Accord, Docetaxel Kabi
- Italy · Docetaxel Aurobindo, Docetaxel Hikma
- Liechtenstein · Docetaxel Accord, Docetaxel Kabi
- Lithuania · Docetaxel Ebewe, Docetaxel Sanoswiss
- Luxembourg · Docetaxel Eugia
- Malta · Docetaxel Hospira
- Norway · Docetaxel Accord, Docetaxel Ebewe
- Poland · Docetaxel Ebewe
- Portugal · Docetaxel Aurovitas, Docetaxel Hikma
- Romania · Docetaxel Teva
- Sweden · Docetaxel Actavis, Docetaxel Ebewe
- Slovenia · Docetaksel Sandoz
- Slovakia · Docetaxel Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f36d7add-7e1d-43b4-831b-a5820cde89c5 GET /v1/drugs/f36d7add-7e1d-43b4-831b-a5820cde89c5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentraat voor oplossing voor infusie",
"route": "Intraveneus gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h132384_smpc.pdf",
"strength": null,
"atc_label": "Docetaxel",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132384",
"excipients": [
"CITROENZUUR 0-WATER (E 330)",
"ETHANOL",
"POLYSORBAAT 80 (E 433)",
"STIKSTOF (HEAD SPACE) (E 941)"
],
"substances": [
"DOCETAXEL 0-WATER"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132384.pdf",
"authorised_at": "2024/12/20",
"procedure_number": "PT/H/1347/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "132384",
"additional_monitoring": "N"
}See everything about docetaxel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.